Looking to publish in Therapeutic Advances In Musculoskeletal Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowTherapeutic Advances in Musculoskeletal Disease is a peer-reviewed open access journal focused on pioneering efforts and innovative studies across all areas of rheumatology, osteoporosis, and related disciplines.
Looking to publish in Therapeutic Advances In Musculoskeletal Disease? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Therapeutic Advances In Musculoskeletal Disease accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
General Reviews
Scoping Reviews
Systematic Reviews
Meta-Analyses
Perspective Reviews
Drug Reviews
Case Reports
Case Series
Brief Reports
Letters To The Editor
Recent Publications
Frequency, diagnosis, and pharmacological treatment of giant cell arteritis in Germany: database analysis of medical insurance data
Wolfgang A. Schmidt, Marco Alibone, Paul Ludwig, Dominik Obermüller, Franziska Karl, Stephanie Terner, Nils Venhoff
Long-term dynamic of muscle mass and its effectors in female patients with rheumatoid arthritis: a 5-year prospective cohort study
Jie Pan, Ying-Ying Zhu, Yao-Wei Zou, Tao Wu, Zhi-Ming Ouyang, Pei-Wen Jia, Jian-Zi Lin, Ye Lu, Ying Yang, Jian-Da Ma, Lie Dai
Real-world performance of EULAR and GRAPPA definitions of difficult-to-treat psoriatic arthritis within the ORCHESTRA cohort: an observational cohort study
Rahaf Zyad Attar, Seyyid Bilal Acikgoz, Elliot Hepworth, Ozun Bayindir Tsechelidis, Ricardo Sabido-Sauri, Tara Swami, Sibel Zehra Aydin
Effectiveness and safety of neridronate in chronic nonbacterial osteomyelitis: insight from the CAMELOT registry
Achille Marino, Andrea Amati, Raffaele Di Taranto, Debora Pireddu, Giulia Grillo, Francesco Baldo, Stefania Costi, Chiara Crotti, Alessandra Curti, Zakaria Vincenzo, Mauro Battista Gallazzi, Massimo Varenna, Roberto Caporali, Cecilia Beatrice Chighizola
Efficacy and safety of dual-targeted therapy with tofacitinib and TNF inhibitors in refractory spondyloarthritis: a case series from a tertiary care center
Aashish Agrawal, Sandeep Sriram Yadav, Canchi Balakrishnan
Frequently asked questions
How long does it take to publish?
Online publication is usually within 3 weeks of acceptance.
Reformat to Therapeutic Advances In Musculoskeletal Disease using Livewrite PremiumIs a cover letter required?
A cover letter is required and should explain why the manuscript is suitable for publication. Writing assistance or third-party submission involvement must also be disclosed in the covering letter.
Reformat to Therapeutic Advances In Musculoskeletal Disease using Livewrite PremiumWhat are the publication costs?
The journal is open access. The standard article processing charge is $3,000 USD. Editorials and Letters to the Editor are free of charge. Plain Language Summary of Publications (PLS-Ps) have an APC of $5000.
Reformat to Therapeutic Advances In Musculoskeletal Disease using Livewrite Premium